Research infrastructure services for rapid research responses to COVID-19 and other infectious disease epidemics
This Horizon Europe program provided critical funding for research infrastructure services to enable rapid responses to COVID-19 and other infectious disease epidemics. It aimed to establish a comprehensive and integrated portfolio of research infrastructure services across Europe, facilitating cutting-edge research to understand, detect, assess, and combat emerging health threats. The initiative fostered international collaboration and promoted open science practices to accelerate the development of new prevention and intervention tools.
Who is Funded
This section details the eligibility criteria for applicants, the geographical scope of the program, and its core objectives. It outlines who can receive funding, where projects must take place, and the overarching strategic goals to be achieved in addressing infectious disease epidemics.
What is Funded
This section outlines the types of projects and thematic areas supported by the program, focusing on infectious diseases and rapid response mechanisms. It clarifies eligible costs and the typical maturity levels of the projects that receive funding.
Type and Scope of Funding
This section provides details on the nature and extent of financial support offered by the program. It specifies the type of financial instrument, the total budget available for the call, and the typical funding amounts per project.
Conditions and Requirements
This section outlines the essential rules, regulations, and specific conditions that applicants and beneficiaries must adhere to. It covers various stipulations, including application terms, requirements for collaboration, and other important provisions to ensure compliance and effective project execution.
Application Procedure
This section provides an overview of the application process for the program. It describes how to submit proposals, the evaluation method, and the timeline for receiving funding decisions.
Legal Basis
This section outlines the fundamental legal and official documents that underpin and govern the funding program. It identifies the primary source of its mandate and other key regulations influencing its operation, as well as where these official texts can be accessed.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
20.998.624 €
Allocated Budget:
21.000.000 €
Deadline:
20.05.2021
Award Channel:
Framework Programme Call
Region:
European Union (EU Member States), Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, Georgia, Iceland, Israel, Kosovo, Moldova, Montenegro, Morocco, North Macedonia, Norway, Serbia, Switzerland, Tunisia, Turkey, Ukraine, United Kingdom. Additionally, Australia, Brazil, Canada, China, India, Japan, Mexico, New Zealand, Republic of Korea, Russia, Singapore, and USA are eligible under specific conditions related to providing research infrastructure access.
Sectors:
Research and Development, Healthcare, Medical Technology, Pharmaceutical Industry, Environmental and Climate Protection, Information and Communication Technology, Social Enterprises
Beneficiaries:
Research institutions, public health bodies, researchers, and industries involved in health and medical research.
Application Type:
Consortium Required
Funding Stages:
Applied Research, Experimental Development, Prototyping, Product Development
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Additional Partners:
European Centre for Disease Prevention and Control (ECDC), World Health Organisation (WHO), World Organisation of Animal Health (OIE), EU Health Emergency Preparedness and Response Authority (EU-HERA) (possible future), National authorities (operational links), European Open Science Cloud (EOSC), European COVID-19 Data Platform, Population Health Information Research Infrastructure for COVID-19 (PHIRI), European Commission's Joint Research Centre (JRC).
Website: